ロード中...
Cancer immunotherapies targeting the PD-1 signaling pathway
Immunotherapy has recently emerged as the fourth pillar of cancer treatment, joining surgery, radiation, and chemotherapy. While early immunotherapies focused on accelerating T-cell activity, current immune-checkpoint inhibitors take the brakes off the anti-tumor immune responses. Successful clinica...
保存先:
| 出版年: | J Biomed Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381059/ https://ncbi.nlm.nih.gov/pubmed/28376884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-017-0329-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|